最新更新 :
01/01/2025
引用文献   引用文献 4835  
种类 : 文献
网络联接 : https://doi.org/10.1186/s40635-020-00311-5

研究小組 : Nottingham - School of Medicine, University of Nottingham, UK
作者 : Hammond S, Wignell A, Cooling P, Barrett D.A, Davies P.
标题 : Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs.
引用文献 : Intensive Care Medecine Experimental 8:25. 2020

可信 : 
物理稳定性 : 
化学稳定性 : 
其它方法 : 
评论 : 

药品清单
注射液Dobutamine hydrochloride 强心剂
兼容 2 mg/ml + Plasmalyte 148 (Baxter)
兼容 2 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
注射液Dopamine hydrochloride 强心剂
兼容 4 mg/ml + Plasmalyte 148 (Baxter)
兼容 4 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
注射液Epinephrine hydrochloride 交感神経系统药
兼容 30 µg/ml + Plasmalyte 148 (Baxter)
兼容 30 µg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
注射液Midazolam hydrochloride 抗焦虑药
不相容 3 mg/ml + Plasmalyte 148 (Baxter)
不相容 3 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
注射液Milrinone lactate 强心剂
兼容 0,2 mg/ml + Plasmalyte 148 (Baxter)
兼容 0,2 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)

  Mentions Légales